Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Singapore Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20141
20171
20182
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Active, not recruiting2
Completed2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Eli Lilly and Company1
GlaxoSmithKline1
Gynecologic Oncology Trial & Investigation Consortium1
Mural Oncology, Inc1
National Cancer Institute (NCI)1
National University Hospital, Singapore1
Pfizer1
Sutro Biopharma, Inc.1
TORL Biotherapeutics, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms11
Ovarian Neoplasms8
Carcinoma, Ovarian Epithelial6
Neoplasms2
Brenner Tumor1
Neoplasm Metastasis1
Pathologic Complete Response1
Peritoneal Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.